Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-02 5:01 pm Sale |
2023-07-18 | 13D | Vera Therapeutics, Inc. VERA |
Carlyle Group Inc. CG |
1,872,764 4.200% |
-544,073 (-22.51%) |
Filing History |
| 2023-07-05 4:17 pm Sale |
2023-06-28 | 13D | Vera Therapeutics, Inc. VERA |
Carlyle Group Inc. CG |
2,416,837 5.500% |
-543,394 (-18.36%) |
Filing History |
| 2023-04-13 4:06 pm Sale |
2023-03-28 | 13D | Vera Therapeutics, Inc. VERA |
Carlyle Group Inc. CG |
2,960,231 6.700% |
-9,925 (-0.33%) |
Filing History |
| 2023-02-16 4:40 pm Purchase |
2023-02-06 | 13D | Vera Therapeutics, Inc. VERA |
Longitude Capital Partners IV LLC | 5,154,137 12.300% |
1,714,285 (+49.84%) |
Filing History |
| 2023-02-16 4:05 pm Purchase |
2023-02-06 | 13G | Vera Therapeutics, Inc. VERA |
Commodore Capital LP | 2,342,857 5.600% |
2,342,857 (New Position) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Vera Therapeutics, Inc. VERA |
RA Capital Management, L.P. | 0 0.000% |
-2,000,000 (Position Closed) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Citadel Advisors LLC | 1,991,553 7.200% |
-50,867 (-2.49%) |
Filing History |
| 2023-02-13 8:43 pm Purchase |
2023-02-06 | 13D | Vera Therapeutics, Inc. VERA |
Sofinnova Venture Partners X L.P. | 3,477,081 8.300% |
285,714 (+8.95%) |
Filing History |
| 2023-02-10 1:20 pm Purchase |
2022-12-30 | 13G | Vera Therapeutics, Inc. VERA |
Kynam Capital Management, LP | 1,409,098 5.100% |
1,409,098 (New Position) |
Filing History |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | Vera Therapeutics, Inc. VERA |
FMR LLC | 4,148,646 15.000% |
1,003,444 (+31.90%) |
Filing History |
| 2023-02-03 7:07 pm Purchase |
2022-03-28 | 13D | Vera Therapeutics, Inc. VERA |
Sofinnova Venture Partners X L.P. | 3,191,367 11.500% |
276,591 (+9.49%) |
Filing History |
| 2023-02-03 5:22 pm Unchanged |
2022-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Kleiner Perkins Caufield & Byers XVI LLC | 1,343,152 4.900% |
0 (Unchanged) |
Filing History |
| 2023-01-27 06:17 am Unchanged |
2022-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Ares Trading S.A. | 1,913,501 6.920% |
0 (Unchanged) |
Filing History |
| 2022-08-11 5:01 pm Purchase |
2022-08-01 | 13D | Vera Therapeutics, Inc. VERA |
Carlyle Group Inc. CG |
2,970,156 11.100% |
2,970,156 (New Position) |
Filing History |
| 2022-04-07 4:39 pm Purchase |
2022-03-28 | 13D | Vera Therapeutics, Inc. VERA |
Abingworth LLP | 2,970,156 11.100% |
9,925 (+0.34%) |
Filing History |
| 2022-04-05 07:36 am Purchase |
2022-02-10 | 13D | Vera Therapeutics, Inc. VERA |
Longitude Capital Partners IV LLC | 3,439,852 12.700% |
343,258 (+11.09%) |
Filing History |
| 2022-02-24 4:30 pm Purchase |
2022-02-14 | 13G | Vera Therapeutics, Inc. VERA |
RA Capital Management, L.P. | 2,000,000 7.500% |
2,000,000 (New Position) |
Filing History |
| 2022-02-14 06:30 am Purchase |
2021-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Citadel Advisors LLC | 2,042,420 9.600% |
17,370 (+0.86%) |
Filing History |
| 2022-02-11 4:51 pm Purchase |
2021-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Kleiner Perkins Caufield & Byers XVI LLC | 1,343,152 6.400% |
1,343,152 (New Position) |
Filing History |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Vera Therapeutics, Inc. VERA |
FMR LLC | 3,145,202 14.999% |
73,306 (+2.39%) |
Filing History |